Aerie Pharmaceuticals, Inc.
(NASDAQ : AERI)

( )
AERI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. -1.34%47.170.0%$200.70m
VRXValeant Pharmaceuticals International, Inc. -1.69%28.5214.1%$167.82m
HZNPHorizon Therapeutics Plc -0.05%116.015.5%$139.52m
ICLRICON plc 0.63%285.142.8%$113.50m
CTLTCatalent, Inc. 2.06%133.582.0%$95.76m
JAZZJazz Pharmaceuticals Plc -3.72%137.372.1%$78.89m
UTHRUnited Therapeutics Corp. -0.47%190.4514.0%$71.32m
PRGOPerrigo Co. Plc -1.18%44.406.9%$70.88m
ARGXargenx SE -1.64%281.850.0%$39.33m
AXSMAxsome Therapeutics, Inc. 1.02%39.691.8%$36.14m
GRVIGrove, Inc. -5.30%5.720.0%$36.02m
PCRXPacira Biosciences, Inc. -0.95%52.419.8%$31.18m
BHCBausch Health Cos., Inc. -1.69%28.520.0%$30.38m
RVNCRevance Therapeutics, Inc. -1.16%14.016.1%$29.90m
ENDPEndo International Plc -7.20%4.388.5%$28.37m

Company Profile

Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on June 22, 2005 and is headquartered in Durham, NC.